Dr. Shroff’s Charity Eye Hospital (SCEH) inaugurates Urmila Khemka Cataract Center with support from Seth Parmanand Khemka Charitable Trust

New Delhi, November 30, 2023:  Dr Shroff’s Charity Eye Hospital inaugurated the ‘Urmila Khemka Cataract Centre (UKCC)’, courtesy Seth Paramanand Charitable Trust, expanding the hospital’s capacity to provide timely and comprehensive care to the patients suffering from cataract and lower the burden of preventable blindness. Set to perform approximately 28,000 surgeries annually, UKCC will aid SCEH in its mission to make a lasting impact on the eradication of blindness in India by providing quality care to all sections of society. It will also contribute to facilitate the quality of life as with operated cataract people are more likely to undertake and spent more time on productive activities and are less likely to report receiving assistance with activities.

Apart from sponsoring the UKCC, Mr. Hari Khemka, Chairman and MD of Aditya Group, has also donated a Phaco machine and provided entire infrastructure support for the centre.

Dr. Umang Mathur, CEO of Dr. Shroff’s Charty Eye Hospital, Daryaganj, said, “An important feature of expanding capacity to treat cataract surgery is that coverage and care can reach everyone including the most disadvantaged populations. It is in this spirit that we have launched the UKCC, increasing the footprint of quality eye care services for all socioeconomic sections of society. The leading causes of avoidable blindness in India are cataract and uncorrected refractive error, and SCEH is on a mission to eliminate the same by building sustainable models of healthcare delivery, enabled by effective partnerships, reducing health inequalities. We believe that access to quality healthcare is a fundamental right, transcending boundaries and social hierarchies.”

Speaking on behalf of the association, Mr. Hari Khemka said, “We are honoured to partner with SCEH, a premier eye care institution, in expanding cataract surgery services to patients across Delhi. This expansion will benefit the most underserved who often have no means to bear the cost of treatment of cataract surgery and live a life of isolation and despair. Diagnosing patients in a timely manner and taking prompt action to combat cataract, will ensure that the burden of this avoidable disease, and its associated economic fallout, is significantly reduced.”

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

5 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

23 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago